OSUR ORASURE TECHNOLOGIES INC

Nasdaq orasure.com


$ 2.40 $ -0.17 (-6.61 %)    

Thursday, 06-Nov-2025 15:59:58 EST
QQQ $ 613.36 $ -9.99 (-1.61 %)
DIA $ 470.23 $ -2.78 (-0.59 %)
SPY $ 671.96 $ -6.30 (-0.93 %)
TLT $ 89.61 $ 0.21 (0.23 %)
GLD $ 367.27 $ -1.11 (-0.3 %)
$ 2.4
$ 2.46
$ 2.29 x 1
$ 2.65 x 913
-- - --
$ 2.30 - $ 4.60
850,590
na
172.16M
$ 0.70
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-05-2025 09-30-2025 10-Q
2 08-06-2025 06-30-2025 10-Q
3 05-07-2025 03-31-2025 10-Q
4 03-07-2025 01-01-1970 10-K
5 11-06-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 03-11-2024 12-31-2023 10-K
9 11-07-2023 09-30-2023 10-Q
10 08-04-2023 06-30-2023 10-Q
11 05-10-2023 03-31-2023 10-Q
12 03-03-2023 12-31-2022 10-K
13 11-08-2022 09-30-2022 10-Q
14 08-09-2022 06-30-2022 10-Q
15 05-10-2022 03-31-2022 10-Q
16 03-01-2022 12-31-2021 10-K
17 11-04-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 03-01-2021 12-31-2020 10-K
21 11-05-2020 09-30-2020 10-Q
22 08-06-2020 06-30-2020 10-Q
23 05-11-2020 03-31-2020 10-Q
24 03-02-2020 12-31-2019 10-K
25 11-08-2019 09-30-2019 10-Q
26 08-07-2019 06-30-2019 10-Q
27 05-09-2019 03-31-2019 10-Q
28 02-28-2019 12-31-2018 10-K
29 11-08-2018 09-30-2018 10-Q
30 08-09-2018 06-30-2018 10-Q
31 05-09-2018 03-31-2018 10-Q
32 02-28-2018 12-31-2017 10-K
33 11-09-2017 09-30-2017 10-Q
34 08-09-2017 06-30-2017 10-Q
35 05-09-2017 03-31-2017 10-Q
36 03-14-2017 12-31-2016 10-K
37 11-08-2016 09-30-2016 10-Q
38 08-08-2016 06-30-2016 10-Q
39 05-10-2016 03-31-2016 10-Q
40 03-14-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 orasure-technologies-sees-q4-sales-25000m-28000m-vs-31180m-est

Financial GuidanceThe Company is guiding to Q4 2025 Total revenues of $25 million to $28 million, which includes less than $100...

 orasure-technologies-q3-adj-eps-013-beats-020-estimate-sales-27085m-miss-28960m-estimate

OraSure Technologies (NASDAQ:OSUR) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of ...

 orasure-technologies-mara-g-aspinall-resigns-john-p-kenny-appointed-as-chair

-SEC Filing

Core News & Articles

Orasure stock price has dropped 11% in 4 weeks, 32% in 12 monthsZwanziger offered $3.50-$4 a share, price now under $3/shareOra...

 orasure-technologies-sees-q3-sales-27000m-30000m-vs-3315m-est

OraSure Technologies (NASDAQ:OSUR) sees Q3 sales of $27.000 million-$30.000 million vs $33.15 million analyst estimate.

 orasure-technologies-q2-adj-eps-019-beats-020-estimate-sales-3124m-beat-3052m-estimate

OraSure Technologies (NASDAQ:OSUR) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of ...

 orasure-technologies-files-for-mixed-shelf-of-up-to-300m

- SEC Filing

 evercore-isi-group-maintains-in-line-on-orasure-technologies-maintains-3-price-target

Evercore ISI Group analyst Vijay Kumar maintains OraSure Technologies (NASDAQ:OSUR) with a In-Line and maintains $3 price ta...

 orasure-technologies-sees-q2-sales-28500m-32500m-vs-3296m-est

OraSure Technologies (NASDAQ:OSUR) sees Q2 sales of $28.500 million-$32.500 million vs $32.96 million analyst estimate.

 orasure-technologies-q1-adj-eps-018-beats-020-estimate-sales-2993m-beat-2918m-estimate

OraSure Technologies (NASDAQ:OSUR) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of ...

 orasure-technologies-sees-q1-sales-27500m-31500m-vs-3238m-est

OraSure Technologies (NASDAQ:OSUR) sees Q1 sales of $27.500 million-$31.500 million vs $32.38 million analyst estimate.

 orasure-technologies-q4-adj-006-inline-sales-3745m-beat-3672m-estimate

OraSure Technologies (NASDAQ:OSUR) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. Thi...

 oraquick-hiv-self-test-gains-approval-for-adolescents-expanding-access-to-hiv-testing-for-ages-14-and-up

The change expands the approved age range to include individuals 14 years of age and older for the OraQuick® HIV Self-Test. Pre...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION